Neoadjuvant Trastuzumab and Pertuzumab for Early HER2-Positive Breast Cancer: A Real World Experience
Table 1
Clinicopathological characteristics at diagnosis and details of final breast and axillary surgery. Gender is not displayed as all patients identified were female. The number of patients having axillary intervention amounts to greater than 100%, as 2 patients had sentinel lymph node biopsy as well as ANC. Axillary lymph node dissection.